Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Spyrou

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
The Biochemical Journal|July 1, 1997
The novel oxidoreductase KDRF (KM-102-derived reductase-like factor) is identical with human thioredoxin reductaseA Miranda-Vizuete, G Spyrou
Medical Informatics and the Internet in Medicine|February 24, 2001
MASTOS: Mammography Simulation Tool for design Optimization StudiesG Spyrou, G Panayiotakis, G Tzanakos
Stoma (Thessalonike, Greece)|May 1, 1971
[Supernumerary teeth, their management in orthodontic procedures]T K Moulas, P G Spyrou
The EMBO Journal|August 1, 1991
Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cellsV Doucas, G Spyrou, M Yaniv
Biochemical and Biophysical Research Communications|September 15, 1988
Deoxycytidine is salvaged not only into DNA but also into phospholipid precursorsT Spasokukotskaja, G Spyrou, M Staub
Biochemical and Biophysical Research Communications|January 24, 1998
Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and FosD Nikitovic, A Holmgren, G Spyrou
Biochemical and Biophysical Research Communications|May 26, 1998
Characterization of phorbolester-inducible human neuronal factors involved in trans-activation of the galanin geneK Jiang, G Spyrou, A Rökaeus
The Journal of Biological Chemistry|April 26, 1996
NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicityM Andersson, A Holmgren, G Spyrou
FEBS Letters|January 2, 1996
High-level expression of fully active human glutaredoxin (thioltransferase) in E. coli and characterization of Cys7 to Ser mutant proteinC A Padilla, G Spyrou, A Holmgren
Journal of Virology|June 1, 1992
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytesF Thierry, G Spyrou, M Yaniv, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
The Biochemical Journal|July 1, 1997
The novel oxidoreductase KDRF (KM-102-derived reductase-like factor) is identical with human thioredoxin reductaseA Miranda-Vizuete, G Spyrou
Medical Informatics and the Internet in Medicine|February 24, 2001
MASTOS: Mammography Simulation Tool for design Optimization StudiesG Spyrou, G Panayiotakis, G Tzanakos
Stoma (Thessalonike, Greece)|May 1, 1971
[Supernumerary teeth, their management in orthodontic procedures]T K Moulas, P G Spyrou
The EMBO Journal|August 1, 1991
Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cellsV Doucas, G Spyrou, M Yaniv
Biochemical and Biophysical Research Communications|September 15, 1988
Deoxycytidine is salvaged not only into DNA but also into phospholipid precursorsT Spasokukotskaja, G Spyrou, M Staub
Biochemical and Biophysical Research Communications|January 24, 1998
Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and FosD Nikitovic, A Holmgren, G Spyrou
Biochemical and Biophysical Research Communications|May 26, 1998
Characterization of phorbolester-inducible human neuronal factors involved in trans-activation of the galanin geneK Jiang, G Spyrou, A Rökaeus
The Journal of Biological Chemistry|April 26, 1996
NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicityM Andersson, A Holmgren, G Spyrou
FEBS Letters|January 2, 1996
High-level expression of fully active human glutaredoxin (thioltransferase) in E. coli and characterization of Cys7 to Ser mutant proteinC A Padilla, G Spyrou, A Holmgren
Journal of Virology|June 1, 1992
Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytesF Thierry, G Spyrou, M Yaniv, et al.
Pageof 8